Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US0028241000
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000B9ZXB4
ABT
Abbott Laboratories
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Medical Devices · THEMEFOLIO: $HLTH
NAME
Abbott Laboratories
ISIN
US0028241000
TICKER
ABT
MIC
XNYS
REUTERS
ABT.N
BLOOMBERG
ABT US
Sun, 30.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 30, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Fri, 28.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 28, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Fri, 28.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 27, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 27.10.2022       Abbott Labs
US0028241000

Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.New York, New York--(Newsfile Corp. - October 27, 2022) - Bernstein Liebhard LLP, a nationally acclaimed investor rights law fi...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 27.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 26, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Tue, 25.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 25, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Tue, 25.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 24, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Abbott and certain...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 24.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 24, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sun, 23.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 23, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Fri, 21.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 21, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 21.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 20.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 20, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 20.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 20, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 20.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 20, 2022) - Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) ***Please contact fmoore@moorekuehn.com.Abbott is a medical device and health care company that provides a b...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 20.10.2022       Abbott Labs
US0028241000

Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.New York, New York--(Newsfile Corp. - October 20, 2022) - Bernstein Liebhard LLP, a nationally acclaimed investor rights law fi...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 19, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 19.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 19, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 17.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 17, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sun, 16.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 16, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sun, 16.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 16, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories (NYSE: ABT) ("Abbott" or the "Company"). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Abbott and certain...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Sun, 16.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 16, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sat, 15.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 14, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 13, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abb...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.10.2022       Abbott Labs
US0028241000

Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.New York, New York--(Newsfile Corp. - October 13, 2022) - Bernstein Liebhard LLP, a nationally acclaimed investor rights law fi...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 13.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 12, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories (NYSE: ABT) ("Abbott" or the "Company") of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 11, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 11, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 9, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead plaintiff deadline.SO WHAT: If you purc...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sat, 08.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 8, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Abbott and certain o...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Fri, 07.10.2022       Abbott Labs
US0028241000

San Francisco, California--(Newsfile Corp. - October 7, 2022) - Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now.Class Period: Feb. 19, 2021 - June 8, 2022Lead Plaintiff Deadline: Oct. 31, 2022Visit: www.hbsslaw.com/investor-fraud/ABTContact An Attorney Now: ABT@hbsslaw.com844-9...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Fri, 07.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 6, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This law...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 06.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 6, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abbo...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 06.10.2022       Abbott Labs
US0028241000

Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.New York, New York--(Newsfile Corp. - October 6, 2022) - Bernstein Liebhard LLP, a nationally acclaimed investor rights law fir...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 06.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 5, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This law...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 5, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abbo...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 4, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This law...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 3, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abbo...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 3, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This law...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.10.2022       Abbott Labs
US0028241000

San Francisco, California--(Newsfile Corp. - October 3, 2022) - Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now.Class Period: Feb. 19, 2021 - June 8, 2022Lead Plaintiff Deadline: Oct. 31, 2022Visit: www.hbsslaw.com/investor-fraud/ABTContact An Attorney Now: ABT@hbsslaw.com844-9...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sun, 02.10.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 2, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Abbo...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sat, 01.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 1, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead plaintiff deadline.SO WHAT: If you purc...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.09.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - September 30, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.09.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - September 29, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.09.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - September 29, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Abbott and certai...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.09.2022       Abbott Labs
US0028241000

Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. New York, New York--(Newsfile Corp. - Se...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.09.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 28, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against A...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.09.2022       Abbott Labs
US0028241000

San Francisco, California--(Newsfile Corp. - September 28, 2022) - Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now.Class Period: Feb. 19, 2021 - June 8, 2022Lead Plaintiff Deadline: Oct. 31, 2022Visit: www.hbsslaw.com/investor-fraud/ABTContact An Attorney Now: ABT@hbsslaw.com...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.09.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 26, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against A...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sun, 25.09.2022       Abbott Labs
US0028241000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 25, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against A...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.09.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - September 24, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead plaintiff deadline.SO WHAT: If you p...
Read more
Abbott Labs
Technical Analysis Termsheets Terminal
Permalink